Open-House-Verträge 2024-2
Buyer: AOK Bremen/Bremerhaven
- Published
- 7 May 2024
- Submission deadline
- 29 May 2026, 17:00
- Place of performance
- DE501
- Procedure
- Open procedure
- Documents
- 1
- Notice number
- 00270104-2024
- Reference
- 33e81827-933c-4361-b179-ed5ecaafadf0
- Official source
- Official source
CPV codes
- 33141110Apósitos
Description
Open-House-Verträge für diverse Wirkstoffe bis 30.06.2026. Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen.
Lots (27)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Amphotericin B, ATC-Code: A01AB04 | 33600000 Productos farmacéuticos | — |
| 2 | Apremilast, ATC-Code: L04AA32 | 33600000 Productos farmacéuticos | — |
| 3 | Dabigatran, ATC-Code: B01AE07 | 33600000 Productos farmacéuticos | — |
| 4 | Dimethylfumarat, ATC-Code: L04AX07 | 33600000 Productos farmacéuticos | — |
| 5 | Etanercept, ATC-Code: L04AB01 | 33600000 Productos farmacéuticos | — |
| 6 | Formoterol, Glycopyrronium und Budesonid, ATC-Code: R03AL11 | 33600000 Productos farmacéuticos | — |
| 7 | Formoterol+Beclometason, ATC-Code: R03AK08 | 33600000 Productos farmacéuticos | — |
| 8 | Goserelin, ATC-Code: L02AE03 | 33600000 Productos farmacéuticos | — |
| 9 | Ibrutinib, ATC-Code: L01EL01 | 33600000 Productos farmacéuticos | — |
| 10 | Ixekizumab, ATC-Code: L04AC13 | 33600000 Productos farmacéuticos | — |
| 11 | Leuprorelin, ATC-Code: L02AE02 | 33600000 Productos farmacéuticos | — |
| 12 | Lipegfilgrastim, ATC-Code: L03AA14 | 33600000 Productos farmacéuticos | — |
| 13 | Methoxy-polyethylenglycol-Epoetin beta, ATC-Code: L03AA14 | 33600000 Productos farmacéuticos | — |
| 14 | Midazolam, ATC-Code: N03AE02 | 33600000 Productos farmacéuticos | — |
| 15 | Mitomycin, ATC-Code: L01DC03 | 33600000 Productos farmacéuticos | — |
| 16 | Octreotid, ATC-Code: H01CB02 | 33600000 Productos farmacéuticos | — |
| 17 | Omalizumab, ATC-Code: R03DX05 | 33600000 Productos farmacéuticos | — |
| 18 | Pegfilgrastim, ATC-Code: L03AA13 | 33600000 Productos farmacéuticos | — |
| 19 | Peginterferon beta-1a, ATC-Code: L03AB13 | 33600000 Productos farmacéuticos | — |
| 20 | Phenprocoumon, ATC-Code: B01AA04 | 33600000 Productos farmacéuticos | — |
| 21 | Pivmecillinam, ATC-Code: J01CA08 | 33600000 Productos farmacéuticos | — |
| 22 | Pomalidomid, ATC-Code: L04AX06 | 33600000 Productos farmacéuticos | — |
| 23 | Pyridostigmin, ATC-Code: N07AA02 | 33600000 Productos farmacéuticos | — |
| 24 | Rilpivirin, ATC-Code: J05AG05 | 33600000 Productos farmacéuticos | — |
| 25 | Somatropin, ATC-Code: H01AC01 | 33600000 Productos farmacéuticos | — |
| 26 | Tetracyclin+Metronidazol, ATC-Code: A02BD08 | 33600000 Productos farmacéuticos | — |
| 27 | Tiotropiumbromid, ATC-Code: R03BB04 | 33600000 Productos farmacéuticos | — |
Official publications
- TED · 00270104-2024 · 7 May 2024
- OJS · 89/2024 · 7 May 2024
Other tenders from AOK Bremen/Bremerhaven
- Verhandlungsbekanntmachung: Versorgung mit Hilfsmitteln der Produktgruppe 23 Orthesen
- Lieferung von IT-Arbeitsplatzhardware
- Open-House-Vergabe 2024-4
- Lieferung von IT-Arbeitsplatzhardware
- Open-House-Verträge 2024-3
- Anmietung von Multifunktionsgeräten
- Open-House-Verträge 2024-3
- Open-House-Verträge 2024-2
- Anmietung von Multifunktionsgeräten
- Open-House-Verträge 2024-2
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 29 May 2026, 17:00. Check the official source, as dates can be modified.
- Who is the buyer of this tender?
- The contracting authority is AOK Bremen/Bremerhaven (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.